JAN
2007
Can a Re-Engineered Kleenex Cure a Brand's Sniffles?†
Assailed by Generics, Kimberly-Clark Bets On a Virus Fighter
Wall Street Journal, January 22, 2007 — Everywhere you look, Kleenex is under siege. Cheap generic tissue is tearing into its market share. Meanwhile, it faces mounting pressure in a consumer-products industry obsessed with infusing even humble paper products with innovation and high-tech ingredients.
Category: Innovation


